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In ureteric  microvessels  the  antagonistic  relationship  between  Ca2+ signalling  in endothelium  and  Ca2+
oscillations  in  myocytes  and  pericytes  of  arterioles  and  venules  involves  nitric  oxide  (NO),  but  the under-
lying mechanisms  are  not  well  understood.  In  the  present  study  we  investigated  the  effects  of  carbachol
and  NO  donor  SNAP  on  Ca2+ signalling  and  vasomotor  responses  of  arterioles  and  venules  in intact  urteric
microvascular  network  in  situ  using  confocal  microscopy.  Vasomotor  responses  of  arterioles  and  venules
induced  by  AVP correlated  with  the  occurrence  of Ca2+ oscillations  in  the myocytes  and  pericytes  and
were not  abolished  by the  removal  of  Ca2+ from  extracellular  ﬂuid.  Carbachol-induced  rise  of  intracel-
lular  Ca2+ in endothelium  was  accompanied  by  the  termination  of  the Ca2+ oscillations  in  myocytes  and
pericytes.  This  carbachol-induced  inhibitory  effect  on  Ca2+ oscillations  in  myocytes  and  pericytes  was
reversed  by ODQ,  an  inhibitor  of  soluble  guanylyl  cyclase  (sGC)  and  by Rp-8-pCPT-cGMPS,  an  inhibitor
of  protein  kinase  G  (PKG).  Ca2+ oscillations  in  myocytes  and  pericytes  were  also  effectively  blocked  by
NO  donor  SNAP.  An  Inhibitory  effect  of SNAP  was  markedly  enhanced  by  zaprinast,  a  selective  inhibitor
of  cGMP-speciﬁc  phosphodiesterase-5,  and  reversed  by sGC  inhibitor,  ODQ  and PKG  inhibitor,  Rp-8-
pCPT-cGMPS.  The  cGMP  analogue  and selective  PKG activator  8pCPT-cGMP  also  induced  inhibition  of  the
2+ 2+AVP-induced  Ca oscillations  in  myocytes  and  pericytes.  SNAP  had  no effects  on Ca oscillations  induced
by  caffeine  in  distributing  arcade  arterioles.  Consequently,  we  conclude  that  NO-  mediated  inhibition  of
Ca2+ oscillations  in  myocytes  and  pericytes  predominantly  recruits  the  cGMP/PKG  dependent  pathway.
The  inhibitory  effect  of NO/cGMP/PKG  cascade  is  associated  with  suppressed  Ca2+ release  from  the SR of
myocytes  and  pericytes  selectively  via  the  inositol  triphosphate  receptor  (IP3R)  channels.
©  2015  The  Authors.  Published  by  Elsevier  Ltd.  This  is  an  open  access  article  under the  CC  BY license
(http://creativecommons.org/licenses/by/4.0/).. Introduction
An endothelial cell (EC) Ca2+ signalling is implicated in regula-
ion of the arteriolar and venular microvascular tone and involves
ntagonistic relationship between Ca2+ signals in endothelial and
edia cells (myocytes and pericytes) [1–6]. For example, dila-
ion of ureteric arterioles and venules [6] or hamster cheek pouch
rterioles [7] in response to the endothelium-dependent vasodila-
or carbachol (CCh) or acetylcholine (ACh) is associated with an
ncrease in ECs Ca2+ signalling which terminates agonist induced
a2+ signals in smooth muscle cells and pericytes. In myocytes
nd pericytes of ureteric microvessels the antagonistic relation-
hip between Ca2+ signalling in endothelium and media cells is
∗ Corresponding author.
E-mail address: L.Borysova@liverpool.ac.uk (L. Borysova).
ttp://dx.doi.org/10.1016/j.ceca.2015.08.006
143-4160/© 2015 The Authors. Published by Elsevier Ltd. This is an open access article uNO-mediated [6]. An increase in the intracellular concentration of
free Ca2+ ([Ca2+]i) in ECs activates Ca2+/calmodulin-dependent con-
stitutive endothelial NO synthase (eNOS) to generate NO, which dif-
fuses to the adjacent myocytes or pericytes and binds to a prosthetic
group on soluble gyanylyl cyclase (sGC). Stimulated sGC catalyses
synthesis of the second messenger cGMP, which in turn activates
cGMP-dependent PKG and/or other effector proteins, including
ion channels, pumps, and phosphodiesterases (PDEs) [8]. Impaired
NO and cGMP signalling have been implicated in the patho-
genesis of cardiovascular disease and atherosclerosis [9–11]. In
large blood vessels ACh-induced dilations are mainly mediated by
NO/cGMP/cGKI pathway [12,13]. The importance of NO and cGMP
for the regulation of vascular tone and blood pressure has been
recently strengthened by the observation that cGMP, eNOS, or cGKI
deﬁciency in mice lead to pathological changes in vascular wall and
hypertension development [12,14,15]. Although, the involvement
of the sGC/cGMP pathway in the pharmacological actions of NO
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Fig. 1. The reversal of an endothelium- dependent inhibition of AVP-induced Ca2+ oscillations in media cells (myocytes and pericytes) by sGC inhibitor, ODQ. (A) Images
showing segments of ureteric arterioles and venules in radial section at rest (i), in the presence of AVP (5 nM) (ii), AVP and CCh (2 M)  (iii), and AVP + CCh + ODQ (25 M)
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piv).  SMC  – smooth muscle cells, EC – endothelial cells, P – pericytes respectively. (
nd  media cells (top trace) of the arcade arterioles (AA), transverse arterioles (TA) a
nd  AVP + CCh + ODQ (n = 7).
s widely accepted, there are data suggesting that alternative NO
ediated cGMP-independent pathways also exist. It is accepted
hat NO- induced vasodilation can be classiﬁed as cGMP-dependent
s long as it is completely inhibited by the selective blocker
f soluble guanylate cyclase, ODQ (1H-[1,2,4]oxadiazole[4,3-
]quinoxalin-1-one) [16–18]. However, in some blood vessels a
ack of ODQ effect on NO-induced inhibition of Ca2+ signalling and
one was reported and contribution of cGMP-independent mecha-
isms was suggested [18–24]. We  hypothesized that in myocytes
nd pericytes of ureteric microvessels, NO activates a cGMP/PKG-
ependent pathway. To test this hypothesis we  examined the
ffects of putative pharmacological modulators of NO/cGMP/PKG
athway on the endothelium- mediated inhibition of AVP-induced
a2+ oscillations in myocytes and pericytes of ureteric microvascu-
ar networks in situ in the absence and the presence of external Ca2+.
o achieve this goal we used our unique methodology developed
ack in 2003 [25] of real time confocal imaging of intact microvas-
ular networks in situ, which allows to monitor simultaneously an
ntracellular [Ca2+] in myocytes, pericytes and endothelial cells and
orrelate it with vasomotor activity [6,26].
. Methods
.1. Animals and ureteric tissue samples
The experiments were performed on Wistar rats of both sexes
3–4 months old). Rats were humanely killed using CO2 anaesthesia
ollowed by cervical dislocation, in accordance with UK legislation.
hole ureters were dissected, carefully cleaned of connective and
araureteric adipose tissue using ﬁne curved scissors and keeping+ traces showing changes in intracellular Ca2+ in single endothelial (bottom trace)
tcapillary venules (PV) at rest and during sequential application of AVP, AVP + CCh,
the sharp edges away from the tissue to avoid physical damage of
the ureteric bundles.
2.2. Calcium and diameter measurements
For Ca2+ measurements ureters were cut into small segments
(4–5 mm long) and loaded with Fluo-4. Strips of ureter were placed
in a plastic cuvette containing 1 ml  of HEPES-buffered Krebs solu-
tion including 15 M-ﬂuo 4-AM dissolved in dimethyl sulphoxide
premixed with Pluronic F127 (ﬁnal concentration of 0.01%). Loading
was performed at 23 ◦C for 3 h with the cuvettes wrapped in black
tape and rotated at 30 rpm. Tissue samples were then removed from
the loading medium and placed in normal Krebs solution for at least
30 min  to allow cleavage of ﬂuo 4-AM to ﬂuo 4 by intracellular
esterases. Fluo-4 loaded segments of ureter were transferred to a
custom-made perfusion chamber mounted on the stage of inverted
Olympus microscope. Superfusion of the ureteric segments in the
chamber was performed by applying a positive pressure valve con-
trolled ﬂow of solution via a 1 mm diameter tip attached to a 3-d
mechanical manipulator (Narishige, Japan) which allowed posi-
tioning the superfusion tip in a desired region of the chamber.
Solution was removed by suction at the other end of the chamber.
All experiments were performed at 30 ◦C. We  used a Nipkow disc,
confocal microscope [6,25,26] (Ultraview, PerkinElmer), connected
to an iXon cooled charge-coupled device camera (Andor Technol-
ogy, UK). Andor Technology iQ or iQ2 data acquisition software
was used for 2- and 3-dimensional confocal imaging of ureteric
microvascular networks in situ. Images were collected at 33–66
frames per second using a ×60 water objective (NA 1.20) for spatial
resolution or dry (×10, NA 0.42; ×20, 0.70 NA) for a larger ﬁeld of
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Fig. 2. The effects of sGC inhibitor ODQ on AVP- and caffeine-induced Ca2+ oscil-
lations in media cells in the presence of SNAP. (A) Ca2+ traces showing ODQ
(25  M)-induced reversal of an inhibitory effect of SNAP (10 M)  on AVP (5 nM)-
induced Ca2+ oscillations in myocytes of AA, TA, precapillary arteriole (PA) and
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Fig. 3. The reversal of inhibitory effects of CCh and SNAP on AVP-induced Ca2+ oscil-
lations in myocytes of AA by PKG inhibitor Rp-8-pCPT-cGMPS in Ca2+-free media.
(A)  Images showing segments of ureteric AA in radial section at rest (i), in the pres-
ence of AVP (5 nM)  (ii), AVP + CCh (2 M) (iii), and AVP + CCh + Rp-8- pCPT-cGMPS
(20  M)  (iv). (B) Ca2+ traces showing that Rp-8-pCPT-cGMPS reversed CCh-induced
inhibition of AVP-activated Ca2+ oscillations in myocytes of AA (n = 7). (C) Ca2+ signal
(top  trace) and diameter change (bottom trace) showing that Rp-8- pCPT-cGMPS
reversed SNAP (10 M)-induced inhibition of AVP-activated Ca2+ oscillations in
myocytes of AA (n = 7). Note that an endothelium-dependent inhibition of AVP-recapillary pericytes of PA (n = 7; (B) Ca traces showing the lack of SNAP and ODQ
ffects on caffeine (1 mM)-induced Ca2+ oscillations in myocytes of AA in (n = 7).
iew. To measure elemental events and Ca2+ waves in myocytes
nd pericytes, tangential sections were used, whereas radial sec-
ions through the centre of the microvessel were used to measure
a2+ events in myocytes, pericytes, endothelial cells and changes in
essel diameter. Mechanical activity of individual smooth muscle
ells was tracked by putting the region of interest close to the edge
f the contracting cell. It was possible to correlate Ca2+ signalling
ith contraction of individual myocytes and pericytes in both radial
nd tangential sections.
.3. Solutions
Physiological saline of the following composition was used
mM):  NaCl 120.4, KCl 5.9, MgSO4 1.2, CaCl2 2, glucose 11.5, and
EPES 11. The Ca2+-free solutions contained 2 mM EGTA. [Arg8]-
asopressin acetate salt (AVP), Carbachol (CCh), Caffeine, Zapri-
ast (ZAP), 1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one (ODQ),induced Ca2+ oscillations was performed in Ca2+ free media (preliminary arteriolar
networks were exposed to Ca2+-free media with 2 mM EGTA for 3 min) suggesting
Ca2+ entry is not important for eNOS activation in ureteric microvessels.
Rp-8-pCPT-cGMPS sodium salt, 8pCPT-cGMP, S-nitroso-N-acetyl-
DL-penicillamine (SNAP) were from Sigma. Fluo-4 acetoxymethyl
ester was from Molecular Probes, Life Technologies, UK.
[Arg8]-Vasopressin acetate salt, Carbachol, Caffeine, Rp-
8-pCPT-cGMPS sodium salt, 8pCPT-cGMP were dissolved in
water; S-nitroso-N-acetyl-DL-penicillamine (SNAP), 1H-[1,2,4]
Oxadiazolo[4,3-a]quinoxalin-1-one (ODQ), Zaprinast in DMSO.
2.4. Statistics
A paired Student’s t test was used to test for signiﬁcant dif-
ferences between means. All statistical values are expressed as
mean ± SEM.
3. Results3.1. Effect of sGC inhibition
To evaluate whether inhibition of AVP (5 nM)-induced Ca2+
oscillations in myocytes and pericytes of arteriolar and venular
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yig. 4. Inhibition of AVP-induced Ca2+ oscillations in myocytes of AA by cGMP ana
bsence (top trace) and presence of 8pCPT-cGMP (100 M)  (bottom trace); (B) effec
efore  (control) and 5 min  after its application (n = 7).
icrovessels by CCh or SNAP is cGMP-dependent, we examined the
ffect of ODQ (25 M),  a selective inhibitor of NO-binding site on
GC, in the presence and absence of external Ca2+. Both myocytes
nd pericytes retain their ability to generate Ca2+ signalling and
one in the absence of an external Ca2+ [6,26]. In these experi-
ents we found that termination of sustained AVP-induced Ca2+
scillations and vasomotor activity in myocytes and pericytes was
ssociated with CCh (2 M)-induced Ca2+ transient in endothelium
nd was reversed by ODQ which had no effect on Ca2+ signalling
n endothelium or myocytes on its own (n = 7, Fig. 1A and B,
upplementary Videos 1 and 2). Furthermore, ODQ reversed an
nhibitory action of SNAP (10 M)  on AVP-induced Ca2+ oscillations
n myocytes and pericytes of arterioles and venules, suggesting an
nvolvement of cGMP/PKG-dependent pathway (n = 7, Fig. 2). Sim-
lar results have been obtained in the absence of an external Ca2+.
ig. 2B also shows that SNAP had no effect on Ca2+ oscillations
nduced by 1 mM caffeine in myocytes of arcade arterioles – the
nly microvessels in ureteric microvascular network which express
unctional RyRs channels [6], suggesting that Ca2+ release mediated
y RyRs channels was not affected by NO/cGMP/PKG cascade (n = 7).
.2. Effects of PKG inhibition
Since the above results suggest that endothelial cell Ca2+
ignalling and NO donor SNAP inhibit Ca2+ oscillations in myocytes
nd pericytes, acting through NO/cGMP-dependent mechanism, we
urther investigated whether PKG mediates CCh- and NO-induced
nhibitory effect on Ca2+ oscillations and tone in myocytes and per-
cytes. We  found that a selective PKG inhibitor Rp-8-pCPT-cGMPS
20 M)  reversed the inhibitory effects of both CCh and SNAP on
VP - induced Ca2+ oscillations and tone in myocytes and pericytes
f all sections of arterioles and venules in the presence or absence
f an external Ca2+ (n = 7, Fig. 3 and Supplementary Video 3). These
esults suggest that PKG is required for NO-induced inhibition of
a2+ oscillations mediated by IP3R channels in ureteric arteriolar
yocytes and venular pericytes (data not shown).
.3. Effect of PKG activation
To support the idea that SNAP effects on Ca2+ oscillations were
ediated by PKG, we studied the effect of the potent PKG activatorGMP analogue 8pCPT-cGMP on the AVP induced Ca2+ oscillations
n myocytes and pericytes of ureteric microvessels. This cGMP
nalogue is permeable to cell membranes, resistant to hydrol-
sis by PDEs, and selective activator of cGMP-dependent PKG. 8pCPT-cGMP. (A) Ca2+ oscillations induced by 5 nM AVP in myocytes of AA in the
pCPT-cGMP (100 M)  on the frequency of AVP-induced Ca2+ oscillations measured
8pCPT-cGMP (100 M)  caused time-dependent decrease in the
amplitude and frequency of Ca2+ oscillations from 0.07 ± 0.002 Hz
to 0.005 ± 0.001 Hz in 60% and completely ceased within 2–5 min  in
40% of myocytes observed (n = 7, Fig. 4). These results suggest that
raising cGMP targets PKG and induce inhibition of AVP-induced
Ca2+ oscillations in myocytes and pericytes, leading to vasodilation.
3.4. Effect of PDE5 blocker zaprinast
Since NO action is mediated by second messenger cGMP with a
short life span, we have examined how cGMP catabolism reduction
by PDE-5-selective inhibitor zaprinast (ZAP) affected NO - sensitive
Ca2+ oscillations in myocytes and pericytes of ureteric microvessels.
In these experiments the microvessels were given a subthreshold
concentration of SNAP (10–50 nM)  in which it had no inhibitory
effect on AVP induced Ca2+ oscillations (n = 5, Fig. 5B) and tone.
Fig. 5A shows that ZAP alone had little or no effect on AVP-induced
Ca2+ oscillations in myocytes and pericytes. However, combined
action of SNAP (10 nM)  and ZAP (20 M)  completely terminated
AVP-induced Ca2+ oscillations in myocytes (n = 5, Fig. 5C) and peri-
cytes of all sections of arteriolar and venular networks (data not
shown). These data suggest that ZAP enhanced SNAP-mediated
inhibition of AVP-induced Ca2+ oscillations of ureteric arterioles
by supressing the cGMP-dependent PDE activity.
4. Discussion
In this study by combining confocal imaging with pharmaco-
logical analysis we  investigated a possible role of NO/cGMP/PKG
signalling cascade in endothelium- mediated Ca2+ dependent
inhibition of agonist-induced Ca2+ oscillations and vasomotor
responses in myocytes and pericytes of ureteric microvessels in
situ. Previously, we  have shown that in myocytes and pericytes
of ureteric microvascular network agonist induced Ca2+ signalling
and vasomotor responses are selectively mediated by IP3R channels
dependent mainly on Ca2+ release from the SR. Similar data have
been obtained on smooth muscle cells of intrapulmonary arterioles
[27]. In addition, we have shown that activation of endothelial Ca2+
signalling by CCh (or bradykinin) terminated agonist-induced Ca2+
oscillations and vasomotor responses in the presence and absence
of an external Ca2+. Furthermore, we have shown that antago-
nistic relationship between Ca2+ signalling in endothelium and
media cells (myocytes and pericytes) was mainly NO-dependent.
Here, we present experimental evidence suggesting that the inhi-
bition of AVP-induced Ca2+ oscillations and vasomotor responses
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Fig. 5. The effect of PDE5 inhibitor ZAP on AVP-induced Ca2+ oscillations in myocytes of TA in the absence and presence of the subthreshold concentration of SNAP. (A and B)
C duced Ca2+ oscillations in single myocytes of AA, respectively; (C) Ca2+ trace showing that
S tions in myocytes of AA in the presence of ZAP (n = 5). The data indicate that suppression
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Fig. 6. Schematic diagram showing signalling pathways involved in antagonistic
relationship between Ca2+ signalling in endothelial and media (myocytes and peri-
cytes) cells in ureteric microvessels. Agonists, such as CCh in endothelial cells (ECs)
and  AVP in myocytes and pericytes bind to their speciﬁc G protein-coupled mem-
brane receptors (GPCR) and activate phospholipase C to synthesize IP3. IP3, in turn,
activates IP3Rs to release Ca2+ from the ER/SR, inducing Ca2+ oscillations. Ca2+ oscil-
lations in ECs activate eNOS to generate NO, and in myocytes and pericytes-myosin
2+a2+ traces showing no effect of ZAP (20 M)  and SNAP (10 nM) on the AVP (5 nM)-in
NAP  in subthreshold concentration completely inhibited AVP-induced Ca2+ oscilla
f  PDE5 signiﬁcantly increased an inhibitory potency of SNAP.
n myocytes and pericytes by CCh-induced endothelial Ca2+ signals
mploys NO/cGMP/PKG-dependent signalling cascade.
First, the inhibitory effects of endothelial cell Ca2+ signalling
nd NO donor SNAP on Ca2+ oscillations of myocytes and peri-
ytes were quickly reversed by ODQ, a speciﬁc inhibitor of sGC
hat is activated by NO and synthesizes cGMP [16–18], and Rp-
-pCPT-cGMPS, a speciﬁc inhibitor of PKG activity [28]. Second,
he membrane-permeable cGMP analogue 8pCPT-cGMP, which is
 selective activator of cGMP-dependent PKG, inhibited Ca2+ oscil-
ations induced by agonists in myocytes and pericytes. Third, in the
resence of zaprinast, a selective inhibitor of cGMP-speciﬁc PDE-
 [28], the inhibitory effect of SNAP was ampliﬁed more than 10
imes. Collectively these data suggest that cGMP- mediated mech-
nism is playing a key role in endothelium-dependent inhibition
f Ca2+ oscillations and vasomotor responses in myocytes and per-
cytes of ureteric microvascular networks in situ. Our data are in a
ood agreement with the data obtained on vascular (rat tail artery)
29] and non-vascular (smooth muscle of airways) [28,30] tissues.
In addition, our data also indicate that NO had no effects on
affeine- induced Ca2+ oscillations in myocytes of distributing
rcade arterioles where functional RyRs have been identiﬁed [6].
O did not inﬂuence the magnitude of the Ca2+ release induced by
affeine. This result indicates that in myocytes of arcade arterioles,
he capacity or Ca2+ stores content was not altered signiﬁcantly
nd that the RyRs remained unaffected by NO, which agrees
ith the previous data [24,28]. Collectively, these results suggest
hat NO, and the resulting increase in cGMP and PKG activity,
ecreased the frequency of agonist-induced Ca2+ oscillations by
educing the activity of the IP3Rs. The molecular mechanism by
hich NO/cGMP/PKG signalling cascade inhibited the IP3R was  not
nvestigated here, but an IP3R-associated cGMP kinase substrate
rotein called IRAG has been identiﬁed in some smooth muscle
ells [31,32]. This protein is associated with the IP3R, is phospho-
ylated by PKG, and upon phosphorylation it blocks IP3R activation
y IP3 and Ca2+; this could be the major mechanism by which
he NO/cGMP/PKG cascade reduces [Ca2+]i and vascular tone [15]
Fig. 6).
light chain kinase (MLCK) to trigger vasoconstriction. NO induces inhibition of Ca
oscillations in myocytes and pericytes by activating sGC to synthesize cGMP from
GTP. The elevation of cGMP activates PKG, which inhibits the IP3R-mediated Ca2+
release (possibly via IRAG phosphorylation), resulting in termination of Ca2+ oscil-
lations in media cells.
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Finally, we conclude that endothelial cell Ca2+ signalling ter-
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hich results in an inhibition of IP3R- mediated Ca2+ mobilization
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